![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Nippon Shinyaku, Janssen Pharmaceutical, Grunenthal to Collaborate
Nippon Shinyaku, Janssen Pharmaceutical, Grunenthal to Collaborate
February 22, 2005
Nippon Shinyaku has mutually agreed with Janssen Pharmaceutical and Grunenthal GmbH to collaborate in the development of Tramadol HCl, an oral analgesic developed by Grunenthal, in Japan. Launched in 1981, Tramadol HCl has been distributed in more than 100 countries worldwide. In Japan, Nippon Shinyaku has been conducting clinical development in the field of cancer pain since 1996.
Japan Corporate News (http://www.japancorp.net/Article.Asp?Art_ID=9457)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct